Company News
Syngene Leadership Overhaul: CEO Change, KMS Executive Role
Syngene's Board approved Kiran Mazumdar Shaw's transition from Non-Executive to Executive Chairperson, effective April 1, 2026, for 5 years.
MD & CEO Peter Bains resigned, effective close of business
